Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. ReplyThe New England journal of medicine, 2023-12, Vol.389 (24), p.2302-2303 [Peer Reviewed Journal]EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2312837 ;PMID: 38091540Full text available |
|
2 |
Material Type: Article
|
1 H -Pyrazolo[3,4- b ]pyridines: Synthesis and Biomedical ApplicationsMolecules (Basel, Switzerland), 2022-03, Vol.27 (7) [Peer Reviewed Journal]EISSN: 1420-3049 ;PMID: 35408636Full text available |
|
3 |
Material Type: Article
|
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaBlood, 2020-02, Vol.135 (7), p.463-471 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019002140 ;PMID: 31841594Full text available |
|
4 |
Material Type: Article
|
Cabozantinib in Patients with Advanced and Progressing Hepatocellular CarcinomaThe New England journal of medicine, 2018-07, Vol.379 (1), p.54-63 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1717002 ;PMID: 29972759Full text available |
|
5 |
Material Type: Article
|
Sotorasib for Lung Cancers with KRAS p.G12C MutationThe New England journal of medicine, 2021-06, Vol.384 (25), p.2371-2381 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103695 ;PMID: 34096690Full text available |
|
6 |
Material Type: Article
|
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisThe Lancet infectious diseases, 2016-07, Vol.16 (7), p.828-837 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(16)00071-2 ;PMID: 26969258 ;CODEN: LANCAOFull text available |
|
7 |
Material Type: Article
|
Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismThe New England journal of medicine, 2018-02, Vol.378 (7), p.615-624 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1711948 ;PMID: 29231094Full text available |
|
8 |
Material Type: Article
|
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast CancerCancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2301-2313 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-15-0728 ;PMID: 27020857Full text available |
|
9 |
Material Type: Article
|
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet (British edition), 2017-01, Vol.389 (10064), p.56-66 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 7, 2017 ;2017. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32453-9 ;PMID: 27932229 ;CODEN: LANCAOFull text available |
|
10 |
Material Type: Article
|
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized studyNeurology, 2018-12, Vol.91 (24), p.e2222-e2232 [Peer Reviewed Journal]2018 American Academy of Neurology ;Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. ;Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. 2018 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000006641 ;PMID: 30446595Full text available |
|
11 |
Material Type: Article
|
Molecular therapies and precision medicine for hepatocellular carcinomaNature reviews. Clinical oncology, 2018-10, Vol.15 (10), p.599-616 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;Springer Nature Limited 2018. ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-018-0073-4 ;PMID: 30061739Full text available |
|
12 |
Material Type: Article
|
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I TrialClinical cancer research, 2021-08, Vol.27 (16), p.4491-4499 [Peer Reviewed Journal]2021 The Authors; Published by the American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-21-0611 ;PMID: 34078652Full text available |
|
13 |
Material Type: Article
|
Treating cancer with selective CDK4/6 inhibitorsNature reviews. Clinical oncology, 2016-07, Vol.13 (7), p.417-430 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2016 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/nrclinonc.2016.26 ;PMID: 27030077 ;CODEN: AJHYE6Full text available |
|
14 |
Material Type: Article
|
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met OverexpressionJournal of clinical oncology, 2016-03, Vol.34 (7), p.721-730 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.4600 ;PMID: 26729443Full text available |
|
15 |
Material Type: Article
|
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 TrialJournal of thoracic oncology, 2021-02, Vol.16 (2), p.299-309 [Peer Reviewed Journal]2020 ;Copyright © 2020. Published by Elsevier Inc. ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2020.10.002 ;PMID: 33166719Full text available |
|
16 |
Material Type: Article
|
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trialThe lancet oncology, 2020-07, Vol.21 (7), p.923-934 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30168-6 ;PMID: 32511981Full text available |
|
17 |
Material Type: Article
|
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Journal of clinical oncology, 2015-08, Vol.33 (24), p.2646-2654 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2014.60.1591 ;PMID: 26169613Full text available |
|
18 |
Material Type: Article
|
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJournal of clinical oncology, 2016-05, Vol.34 (13), p.1448-1454 [Peer Reviewed Journal]2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.5995 ;PMID: 26884585Full text available |
|
19 |
Material Type: Article
|
Cabozantinib in patients with advanced RET -rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trialThe lancet oncology, 2016-12, Vol.17 (12), p.1653-1660 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30562-9 ;PMID: 27825636 ;CODEN: LANCAOFull text available |
|
20 |
Material Type: Article
|
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialThe Lancet (British edition), 2019-10, Vol.394 (10206), p.1335-1343 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31872-0 ;PMID: 31492505Full text available |